Standard long-acting insulin as good as newer medications

An older type of long-acting insulin is as effective in treating type 2 diabetes as newer and more expensive kinds, according to the results of a recent systematic review. However, the newer medications may cause fewer problems with low blood glucose while patients are sleeping.

People with type 2 diabetes who need insulin take once-a-day insulin for longer-lasting or "basal" control. (The review did not cover shorter-acting insulins used to control the blood glucose spike that comes from eating.)

Doctors consider the older medication, NPH, to be the current gold standard for basal insulin. Newer drugs, insulin analogues such as insulin glargine (trade name Lantus) and insulin detemir (Levemir), have been marketed as an improvement over NPH.

However, the reviewers found that Lantus and Levemir were almost identical to NPH in lowering levels of hemoglobin A1c, a widely used measure of long-term blood glucose control.

The eight studies analyzed had enrolled 2,293 people and were published in major medical journals. The studies lasted between 24 and 52 weeks.

The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.

The reviewers said their study indicated "only a minor clinical benefit" came from using the newer drugs for those with type 2 diabetes when they looked at overnight low blood glucose. They suggested a "cautious approach" when using Lantus or Levemir, at least until longer studies of the effectiveness and safety of the newer medications are completed.

Although NPH is less expensive than the other drugs, the reviewers could not come to any conclusion on cost-effectiveness or the effect of any of the dr

Contact: Lisa Esposito
Center for the Advancement of Health

Page: 1 2

Related medicine news :

1. Standard developed for collection of suspicious powders
2. Standardized guidelines improve outcomes in stroke care
3. No benefit for liver cancer patients from long-acting octreotide
4. Exercise lowers insulin in breast cancer survivors
5. Study tests oral insulin to prevent type 1 diabetes
6. How insulin-producing cells develop -- new finding could help fight against diabetes
7. Low-glycemic load diet may be more effective for dieters with certain insulin response patterns
8. LAP-BAND System surgery improves insulin resistance
9. New project to analyze why Polycystic Ovary Syndrome and insulin resistance are so closely linked
10. Study tests oral insulin to prevent type 1 diabetes
11. Race may be risk factor for insulin resistance

Post Your Comments:

(Date:7/10/2020)... ... July 09, 2020 , ... ... and behavioral health announces that Ohio Department of Medicaid has awarded CellTrak Phase ... Many agencies in Ohio already rely on CellTrak for EVV – both as ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... unmet needs in the field of urology, today announced that Carl Meyer, M.D., ... UroLift® Center of Excellence. The designation recognizes that Dr. Meyer has achieved a ...
(Date:7/7/2020)... ... ... Mediaplanet recently launched an awareness initiative to inspire more people to pursue ... the spotlight and, as a result, the Bureau of Labor Statistics predicts job growth ... University — which offers a Master’s in Public Health degree program both online ...
(Date:7/7/2020)... ... July 07, 2020 , ... ... or two head design to efficiently sanitize large surfaces is now available in ... available to support sales in that region. , In this era of worldwide ...
(Date:7/4/2020)... ... July 03, 2020 , ... MemoryCare.com , ... announced the Best Memory Care Facilities in Charleston, South Carolina. The guide identifies ... amenities. , According to the Alzheimer’s Association , 5.6 million people ...
Breaking Medicine News(10 mins):
(Date:7/2/2020)... ... July 02, 2020 , ... Realty ... a four-part health series on its live agent Town Halls, furthering its commitment ... work. The series includes special guests and Realty ONE Group leadership discussing social, ...
(Date:7/1/2020)... ... July 01, 2020 , ... ... (PDT) for treating cancer, today announced the formation of its Scientific Advisory Board ... provide critical medical, scientific, and strategic advice to support company development and introduction ...
(Date:6/28/2020)... ... June 27, 2020 , ... CPAP Store USA, known ... along with other respiratory devices, is growing and expanding at a rapid rate. Today, ... location in Texas - CPAP Store Dallas, located at 3920 Rosemeade Parkway, Suite 150, ...
Breaking Medicine Technology:
Cached News: